The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Cardiovascular Disease Under the Influence of Excess Visceral Fat
Abstract
Diabetes and cardiovascular disease have emerged as major threats to human health, and the risk of developing these chronic conditions is increased in individuals with abdominal obesity and the metabolic syndrome. Excess visceral abdominal tissue (VAT) accumulation appears to be a key feature of abdominal obesity contributing to the development of the metabolic syndrome. For instance, excess VAT is accompanied by elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol, elevated blood pressure, and/or elevated fasting plasma glucose. In addition, the rather normal or only marginally elevated low-density lipoprotein (LDL) cholesterol concentrations in patients with excess VAT could provide misleading information as viscerally obese patients have an increased plasma concentration of small, dense LDL particles. Prospective studies have suggested that even among patients with LDL cholesterol concentrations within normal limits, an increased concentration of small LDL particles is associated with higher risk of cardiovascular disease. With the treatment of abdominal obesity and excess VAT, an increase in patients' LDL particle size and improvements in other cardiovascular risk factors (eg, insulin levels, glucose tolerance, HDL, C-reactive protein [CRP], and adiponectin levels) can be achieved. Waist circumference can be used in clinical practice as a first approach and as a crude index to identify patients who have excess VAT, particularly when the elevated waistline is accompanied by the clinical features of the metabolic syndrome, among which an elevated fasting triglyceride concentration appears to be predictive of a reduced LDL particle size and of further metabolic abnormalities frequently referred to as the metabolic syndrome. Lifestyle changes, including more physical activity and healthier nutritional habits, are the cornerstone of therapy for high-risk abdominally obese patients with an excess of VAT. In addition, results from the RIO-Lipids study, which was conducted in high-risk obese, dyslipidemic patients, have provided evidence that CB1 receptor blockade with rimonabant can induce significant weight loss, and, more importantly, improve the cardiometabolic risk profile beyond what could be explained by the weight loss effects of the drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Cited by
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319
Sex differences in human adipose tissues – the biology of pear shape
Karastergiou, K., Smith, S. R., Greenberg, A. S., & Fried, S. K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-13 · Cited by 1,109
“The clinical significance of body fat distribution is supported by multiple epidemiological studies that confirm the detrimental effect of central body and the protective effect of gluteal-femoral fat on diabetes [81,82], cardiovascular risk and eventually morbidity and mortality [1,76,83-89].”
BackgroundVisceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease
Mathieu, P., Poirier, P., Pibarot, P., Lemieux, I., & Després, J.-P. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.110320 · Cited by 490
Jayedi, A., Soltani, S., Zargar, M. S., Khan, T. A., & Shab-Bidar, S. (2020) · BMJ · doi:10.1136/bmj.m3324 · Cited by 396
Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective
Arnardottir, E. S., Mackiewicz, M., Gislason, T., Teff, K. L., & Pack, A. I. (2009) · Sleep · doi:10.1093/sleep/32.4.447 · Cited by 345
Salgado-Delgado, R., Angeles-Castellanos, M., Saderi, N., Buijs, R. M., & Escobar, C. (2010) · Endocrinology · doi:10.1210/en.2009-0864 · Cited by 323
Obesity and cardiovascular disease: An ESC clinical consensus statement
Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae508 · Cited by 313
Luu, Y. K., Capilla, E., Rosen, C. J., Gilsanz, V., Pessin, J. E., Judex, S., & Rubin, C. T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080817 · Cited by 267
Kang, S. M., Yoon, J. W., Ahn, H. Y., Kim, S. Y., Lee, K. H., Shin, H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027694 · Cited by 197
Elder, S. J., Lichtenstein, A. H., Pittas, A. G., Roberts, S. B., Fuss, P. J., Greenberg, A. S., McCrory, M. A., Bouchard, T. J., Saltzman, E., & Neale, M. C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900033-jlr200 · Cited by 139
Varady, K. A., Bhutani, S., Klempel, M. C., & Kroeger, C. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-119 · Cited by 116
“Overweight and obesity are associated with an atherogenic lipoprotein phenotype that is characterized by the predominance of small LDL and HDL particles [7].”
BackgroundAlbrecht, S. S., Gordon-Larsen, P., Stern, D., & Popkin, B. M. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.71 · Cited by 51
Varady, K. A., Bhutani, S., Klempel, M. C., & Lamarche, B. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510003788 · Cited by 39
Raoux, L., Moszkowicz, D., Vychnevskaia, K., Poghosyan, T., Beauchet, A., Clauser, S., Bretault, M., Czernichow, S., Carette, C., & Bouillot, J.-L. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2292-z · Cited by 34
Kanellakis, S., Kourlaba, G., Moschonis, G., Vandorou, A., & Manios, Y. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.10.012 · Cited by 25
Metadata
- Authors
- Després, J.-P.
- Venue
- Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Published
- 2007-06
- Volume
- 6
- Issue
- 2
- Pages
- 51-59
- ISSN
- 1535-2811 (ISSN-L)
- 1535-282X
- OpenAlex
- W2309457374
- Cited by
- 198
- References
- 26
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.